Represent Lehman Bros. in $350-million contract and fraud case in Tokyo District Court.
Japan Commercial Arbitration
(Japan Commercial Arbitration Association). Representation of a Japanese joint venture partner in a dispute between the U.S. partner and joint venture regarding technology licensing with respect to semiconductor manufacturing equipment.
Telecommunication Company Arbitration
(HKIAC). Representated a Cayman Islands telecommunications company before HKIAC in a dispute with Chinese telecommunications company in an arbitration involving the breach of an asset purchase agreement.
ICC Arbitration for major Japanese industrial company
(ICC). Successfully represented a major Japanese industrial company before the ICC in a breach of contract case arising out of construction of a steel mill in Brazil.
In re IXI Litigation
(Tokyo District Court). Currently represent Dell, Inc., and its subsidiary Dell Japan, in series of litigation proceedings in Tokyo and Osaka District Courts relating to certain transactions for Dell goods and services.
Kuwait Petroleum Corporation v. Arabian Oil Company.
(London Court of International Arbitration). Successfully settled a dispute under a long-term oil supply agreement between our client Arabian Oil Company (AOC), a Japanese oil and gas company, and Kuwait Petroleum Corporation (KPC) in which KPC sought upwards of $8 million for alleged underlifting by AOC. The agreement was governed by English law and provided for all disputes to be resolved by arbitration under the LCIA Rules in London.
Palermo 34 v. Hill's-Colgate.
(Osaka District Court / Osaka High Court). Represented Colgate-Palmolive in a products liability case before the Osaka District Court involving Hills' Science Diet pet food.
Syntron Bioresearch v. Genix Biotek
(California Court of Appeals, Fourth Appellate District). Secured a $12.5-million judgment and permanent injunction on behalf of our client Syntron Bioresearch in a trade secret and trademark case against former employees accused of stealing monoclonal antibodies, hybridoma cell lines, and production processes used in manufacturing immunoassays.
Trial for Invalidation of Patent No. 3638738
(Japan Patent Office). Represented Albemarle Corp. in a series of petitions for invalidity filed with the JPO.